The Discounted Cash Flow (DCF) valuation of Sarepta Therapeutics Inc (SRPT) is (284.62) USD. With the latest stock price at 125.39 USD, the upside of Sarepta Therapeutics Inc based on DCF is -327.0%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 9.3% | 8.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (663.59) - (187.94) | (284.62) |
| Upside | -629.2% - -249.9% | -327.0% |